Clinical Trials
2 trialsNCT07256015 2025-12-01
Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
Bristol-Myers Squibb
Recruiting
NCT06952465 2025-05-01
A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis
Bristol-Myers Squibb
Active not recruiting